Treo/Flu/TBI With Donor Stem Cell Transplant for Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia
- Status
- UNKNOWN
- Phase
- PHASE2
Clinical Trials Related to Myelodysplastic Syndrome
Related studies linked through entity extraction aliases.
Clofarabine and Melphalan Before Donor Stem Cell Transplant in Treating Patients With Myelodysplasia, Acute Leukemia in Remission, or Chronic Myelomonocytic Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Phase 2 Study of Pracinostat With Azacitidine in Patients With Previously Untreated Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE2
PENELOPE Observational Study: Prophylaxis and Treatment of Arterial and Venous Thromboembolism
- Status
- COMPLETED
- Phase
- N/A
DEC-205/NY-ESO-1 Fusion Protein CDX-1401and Decitabine in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
Study of New RIC Regimen of BuFlu in Older and/or Intolerable Patients
- Status
- UNKNOWN
- Phase
- N/A
Birinapant With 5-azacitidine in MDS Subjects Who Are Naïve, Have Relapsed or Are Refractory to 5-azacitidine Therapy
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Donor Natural Killer Cells and Donor Stem Cell Transplant in Treating Patients With High Risk Myeloid Malignancies
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Phase I/II Study of Immune Therapy After Allograft in Patients With Myeloid Hemopathy
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Chemotherapy in Treating Patients With Myelodysplastic Syndrome Before Donor Stem Cell Transplant
- Status
- COMPLETED
- Phase
- PHASE2
Liposomal Cytarabine-Daunorubicin CPX-351 in Treating Patients With Untreated Myelodysplastic Syndrome or Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- NA
Safety and Efficacy Study of PD-616 Plus Cytarabine to Treat Acute Myelogenous Leukemia or Myelodysplastic Syndrome
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Safety and Efficacy of Donor T-lymphocytes Depleted ex Vivo of Host Alloreactive T-cells (ATIR) in Patients With a Hematologic Malignancy Who Received a Hematopoietic Stem Cell Transplantation From a Haploidentical Donor
- Status
- COMPLETED
- Phase
- PHASE2
GVAX vs. Placebo for MDS/AML After Allo HSCT
- Status
- TERMINATED
- Phase
- PHASE2
Unrelated Umbilical Cord Blood (UBC)Transplantation
- Status
- COMPLETED
- Phase
- NA
Reduced-Intensity Conditioning Before Donor Stem Cell Transplant in With High-Risk Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE2
Ipilimumab in Treating Patients With Relapsed or Refractory High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
An Effectiveness and Safety Study of Decitabine in Patients With Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE3
Comparison Between Cyclophosphamide and Combination of Methotrexate + Calcineurin Inhibitor for GVHD Prophylaxis
- Status
- TERMINATED
- Phase
- PHASE3
Addition of Vorinostat to Azacitidine in Higher Risk MDS a Phase II add-on Study in Patients With Azacitidine Failure
- Status
- TERMINATED
- Phase
- PHASE2